The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma (Q63340718)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
clinical trial

    Statements

    DRBEAT (English)
    0 references
    A Phase 2a Study of the Addition of Temozolomide to a Standard Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed and Refractory Central Nervous System (CNS) Lymphoma (English)
    0 references
    14 October 2010
    0 references
    28 July 2017
    0 references
    11
    0 references
    18 year
    0 references
    75 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit